Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
developed a drug-delivery system loaded with temozolomide based on porous silicon NPs to improve the survival of mice with glioma
source- Financial express #Healthcare #Pharma #GLP1 #WeightLossDrugs #IndianPharma #HealthcareInvesting #PharmaceuticalIndustry #IndiaGrowthStory #Biotech #HealthcareInnovation #ObesityTreatment To view or add a comment, sign in Indias GLP-1 market is set for a major shift as MANKIND PHARMA LTD targets an early launch of semaglutide following the expected patent expiry in March 2026
However, a vitamin C serum isnt a one-size-fits-all solution
retinol drives cell turnover and inhibits collagen-degrading enzymes at the epidermal level
BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) launches in Medicare Part D January 2027
